Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
» 1999 Initial Public Offerings - After-Market Performance
1999 Initial Public Offerings - After-Market Performance
Jan. 1, 2000
Top Ten Underwriters
Full Credit To All Underwriters
Underwriter (Number of IPOs as Lead/Number of IPOs As Lead Or Co-Manager)
Percent Change In Stock Price
Deutsche Banc Alex. Brown (1/1)
283.0
A.G. Edwards & Sons (1/1)
283.0
Goldman, Sachs & Co. (1/2)
261.0
Robertson Stephens (0/2)
261.0
Invemed Associates (0/2)
229.0
Donaldson, Lufkin & Jenrette (1/2)
207.0
Warburg Dillon Read LLC (0/3)
203.0
China Everbright Securities (0/1)
189.0
The New China Hong Kong Securities Ltd. (0/1)
189.0
Westport Resources Investment Services Inc. (1/1)
189.0
Full Credit To All Underwriters
Underwriter (Number of IPOs as Lead/Number of IPOs As Lead Or Co-Manager)
Percent Change In Stock Price (Post-IPO to Year-End)
Canaccord Capital Corp. (1/1)
181
Merrill Lynch & Co. (0/1)
177
Prudential Vector Healthcare# (1/2)
162
U.S. Bancorp Piper Jaffray (1/2)
145
Lehman Brothers (1/1)
131
J.P. Morgan & Co. (2/3)
116
Credit Suisse First Boston Corp. (1/1)
114
Chase H&Q (0/2)
92
ING Barings (1/1)
53
Schroders & Co. Inc. (0/2)
52
CIBC Wood Grundy Securities Inc. (0/1)
51
Goepel McDermid Inc. (0/1)
51
Nesbitt Burns (1/1)
51
RBC Dominion Securities Inc. (0/1)
51
Punk Ziegel & Co. (0/1)
42
Robert W. Baird & Co. (0/1)
39
Adams Harkness & Hill (0/1)
38
Pro-Genesis Securities (1/1)
19
Leerink Swann & Co. (0/1)
-10
Note: # May include offerings handled by Prudential Securities and Vector Securities International Inc. prior to their merger.
Article reprints
To read more on related topics, click on one of the words below.
BioWorld MedTech
Related Articles
After-Market Performance: Initial Public Offerings-After-Market Performance
Underwriters' Performance On All Public Offerings For 1999: Full Credit To Lead Underwriter, Ranked By After-Market Performance*
Underwriters' Performance on All Public Offerings For 1999: Full Credit to All Underwriters, Ranked By After-Market Performance*
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe